Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of indi- vidual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903 13. S3.1-2. Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1 25 million people. Lancet. 2014;383:1899 911. S3.1-3. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957 67. S3.1-4. Guo X, Zhang X, Guo L, et al. Association between pre-hyperten- sion and cardiovascular outcomes: a systematic review and meta- analysis of prospective studies. Curr Hypertens Rep. 2013;15: 703 16. S3.1-5. Guo X, Zhang X, Zheng L, et al. Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies. PLoS ONE. 2013;8:e61796. S3.1-6. Huang Y, Cai X, Li Y, et al. Prehypertension and the risk of stroke: a meta-analysis. Neurology. 2014;82:1153 61. S3.1-7. HuangY, Cai X, Liu C, et al. Prehypertension and the risk of coro- nary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc. 2015;4:e001519. S3.1-8. Huang Y, Cai X, Zhang J, et al. Prehypertension and incidence of ESRD: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63:76 83. S3.1-9. Huang Y, Su L, Cai X, et al. Association of all-cause and cardiovas- cular mortality with prehypertension: a meta-analysis. Am Heart J. 2014;167:160 8.e1. S3.1-10. Huang Y, Wang S, Cai X, et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013; 11:177. S3.1-11. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. S3.1-12. 